Spironolactone Tablet
Product Images NDC 68071-3903

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3903 9)

Label for Spironolactone 100 mg tablets by NuCare Pharmaceuticals, Inc., showing a bottle with 90 tablets. The label includes the NDC number 68071-3903-9 and describes the tablets as round, biconvex, white to almost white, debossed with 'SP' and 'IT' above and below a score line and '100' on the other side. Packaging and manufacturing details include Aurobindo Pharma Limited, India. Instructions and warnings about storage temperature and keeping out of reach of children are also visible.*

FDA Label Image

Figure (Spironolactone Fig1)

A Kaplan-Meier survival curve comparing the probability over months between two groups: Spironolactone (n=822) and placebo (n=841). The x-axis represents time in months up to 48, and the y-axis shows probability from 0 to 1. The Spironolactone group shows a higher survival probability over time compared to placebo. The graph includes a log-rank p-value of less than 0.001.*

FDA Label Image

Fig2 (Spironolactone Fig2)

A forest plot chart depicting hazard ratios (HR) and their 95% confidence intervals (CI) for different subgroups in a study. Subgroups include age groups, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors (ACEI), or beta blockers. The x-axis ranges from 0.2 to 1.4, with indicators showing where spironolactone is better versus placebo.*

FDA Label Image

Str1 (Spironolactone Str1)

Chemical structure of spironolactone, depicting the arrangement of multiple interconnected rings and functional groups characteristic of the compound used as an active ingredient in spironolactone tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.